Insider · CIK 0001234773
Thomas M Prescott
Files at PRCT (PROCEPT BioRobotics Corp). First filing -, latest -.
In brief
Thomas M Prescott files SEC Form 4 as director at PRCT (PROCEPT BioRobotics Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Thomas M Prescott has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | PRCT PROCEPT BioRobotics Corp | AGrant or award Common Stock | +3,315 | $0.00 | $0 | 7,211 | Jun 10, 2026 |
| Jun 9, 2026 | PRCT PROCEPT BioRobotics Corp | AGrant or award Stock Option (Right to Buy)derivative | +5,853 | $0.00 | $0 | 5,853 | Jun 10, 2026 |
| Jun 10, 2025 | PRCT PROCEPT BioRobotics Corp | AGrant or award Common Stock | +1,538 | $0.00 | $0 | 3,896 | Jun 12, 2025 |
| Jun 10, 2025 | PRCT PROCEPT BioRobotics Corp | AGrant or award Stock Option (Right to Buy)derivative | +2,771 | $0.00 | $0 | 2,771 | Jun 12, 2025 |
Questions about Thomas M Prescott
Answered from the filings on this page, as of the latest one.
Is Thomas M Prescott buying or selling?
Thomas M Prescott has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Thomas M Prescott's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Thomas M Prescott has 0.
Where does Thomas M Prescott file Form 4?
Thomas M Prescott has filed Form 4 at PRCT (PROCEPT BioRobotics Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.